Electronic Medication Alerting Systems and Glucagon-like Peptides Agonists and Sodium-glucose-like Cotransporter 2 Inhibitors
- Denton-Hurst N. ,
- Horn N. ,
- Russell S. ,
- et al
- Denton-Hurst N. ,
- Horn N. ,
- Russell S. ,
- Clark W. and
- Ellis J.
2024
Repository
Description
Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and Glucagon-like-peptide 1 agonists (GLP1a) represent two novel medications with perioperative complications, including euglycemic ketoacidosis and delayed gastric emptying. Electronic health alert systems are valuable tools that aid healthcare providers in enhancing patient safety and ensuring treatment efficacy. Anesthesia providers need more resources, such as alerting systems, to help identify potential perioperative complications associated with SGLT2i and GLP1a medications. This study aims to evaluate complications related to SGLT2i and GLP1a and assess the possible role of electronic health alerting systems in addressing them.
Show Full Abstract
Collapse Abstract
Subjects
Record Data:
- Program:
- CRNA
- Location:
- Knoxville
To access the file, please log in.